Cargando…

Cognitive Impairement in Non-Cirrhotic Portal Hypertension: Highlights on Physiopathology, Diagnosis and Management

Hepatic encephalopathy (HE) is one of the most frequent complications of cirrhosis. Several studies and case reports have shown that cognitive impairment may also be a tangible complication of portal hypertension secondary to chronic portal vein thrombosis and to porto-sinusoidal vascular disease (P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gioia, Stefania, Nardelli, Silvia, Riggio, Oliviero, Faccioli, Jessica, Ridola, Lorenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745274/ https://www.ncbi.nlm.nih.gov/pubmed/35011842 http://dx.doi.org/10.3390/jcm11010101

Ejemplares similares

Causes and Management of Non-cirrhotic Portal Hypertension
por: Gioia, Stefania, et al.
Publicado: (2020)

Identifying Patients at High Risk of Developing Non-Cirrhotic Portal Hypertension
por: Gioia, Stefania, et al.
Publicado: (2021)

Minimal Hepatic Encephalopathy Affects Daily Life of Cirrhotic Patients: A Viewpoint on Clinical Consequences and Therapeutic Opportunities
por: Faccioli, Jessica, et al.
Publicado: (2022)

Nutrition Assessment and Management in Patients with Cirrhosis and Cognitive Impairment: A Comprehensive Review of Literature
por: Faccioli, Jessica, et al.
Publicado: (2022)

Sarcopenia and cognitive impairment in liver cirrhosis: A viewpoint on the clinical impact of minimal hepatic encephalopathy
por: Nardelli, Silvia, et al.
Publicado: (2019)

Transjugular Intrahepatic Portosystemic Shunt Placement: Effects on Nutritional Status in Cirrhotic Patients
por: de Felice, Ilaria, et al.
Publicado: (2023)

Hepatic Encephalopathy: Diagnosis and Management
por: Ridola, Lorenzo, et al.
Publicado: (2020)

Neurological and psychiatric effects of hepatitis C virus infection
por: Faccioli, Jessica, et al.
Publicado: (2021)

Determinants of prognosis in cirrhosis: a new outlook
por: Ridola, Lorenzo, et al.
Publicado: (2022)

Primary Prophylaxis of Overt Hepatic Encephalopathy: Is It Time to Consider It?
por: Faccioli, Jessica, et al.
Publicado: (2023)

Is porto sinusoidal vascular disease to be actively searched in patients with portal vein thrombosis?
por: Gioia, Stefania, et al.
Publicado: (2019)

Old and New Precipitants in Hepatic Encephalopathy: A New Look at a Field in Continuous Evolution
por: Bellafante, Daniele, et al.
Publicado: (2023)

Quality of life in patients with minimal hepatic encephalopathy
por: Ridola, Lorenzo, et al.
Publicado: (2018)

Minimal hepatic encephalopathy and sleep disorders in patients with cirrhosis: Which comes first?
por: Ridola, Lorenzo, et al.
Publicado: (2020)

The improvement in body composition including subcutaneous and visceral fat reduces ammonia and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt
por: Gioia, Stefania, et al.
Publicado: (2021)

Hepatitis C virus eradication with directly acting antivirals improves health-related quality of life and psychological symptoms
por: Nardelli, Silvia, et al.
Publicado: (2019)

Spontaneous porto-systemic shunts in liver cirrhosis: Clinical and therapeutical aspects
por: Nardelli, Silvia, et al.
Publicado: (2020)

Ammonia and the Muscle: An Emerging Point of View on Hepatic Encephalopathy
por: Di Cola, Simone, et al.
Publicado: (2022)

Idiopathic noncirrhotic portal hypertension: current perspectives
por: Riggio, Oliviero, et al.
Publicado: (2016)

Small hepatic veins Budd-Chiari syndrome and paroxysmal nocturnal hemoglobinuria - The association of two rare entities: a case report
por: Gioia, Stefania, et al.
Publicado: (2020)

Idiopathic Non Cirrhotic Portal Hypertension and Spleno-Portal Axis Abnormalities in Patients with Severe Primary Antibody Deficiencies
por: Pulvirenti, Federica, et al.
Publicado: (2014)

The burden of minimal hepatic encephalopathy: from diagnosis to therapeutic strategies
por: Ridola, Lorenzo, et al.
Publicado: (2018)

Hepatic Encephalopathy in the 21st Century: Still an Emerging Topic
por: Ridola, Lorenzo, et al.
Publicado: (2021)

Non-Cirrhotic Portal Hypertension in Systemic Lupus Erythematosus
por: Suárez-Díaz, Silvia, et al.
Publicado: (2023)

Gastrointestinal Bleeding in Cirrhotic Patients with Portal Hypertension
por: Biecker, Erwin
Publicado: (2013)

Wall shear stress in portal vein of cirrhotic patients with portal hypertension
por: Wei, Wei, et al.
Publicado: (2017)

The Impact of Partial Splenic Embolization on Portal Hypertensive Gastropathy in Cirrhotic Patients with Portal Hypertension
por: Saeki, Michio, et al.
Publicado: (2023)

Non-invasive tests for fibrosis detection: still in search for the best way
por: Ridola, Lorenzo, et al.
Publicado: (2022)

Helicobacter pylori and portal hypertensive gastropathy: any new information?
por: Zullo, Angelo, et al.
Publicado: (2014)

Cardiac dysfunction in cirrhotic portal hypertension with or without ascites
por: Dadhich, Sunil, et al.
Publicado: (2014)

Idiopathic non-cirrhotic portal hypertension: a review
por: Schouten, Jeoffrey NL, et al.
Publicado: (2015)

The beneficial effects of curcumin in cirrhotic rats with portal hypertension
por: Hsu, Shao-Jung, et al.
Publicado: (2017)

Research progress on signaling pathways in cirrhotic portal hypertension
por: Xu, Wen, et al.
Publicado: (2018)

Cirrhotic portal hypertension: From pathophysiology to novel therapeutics
por: Gunarathne, Lakmie S, et al.
Publicado: (2020)

Non-cirrhotic portal hypertension in an ankylosing spondylitis patient
por: Park, Sukki, et al.
Publicado: (2018)

Statins activate the canonical hedgehog-signaling and aggravate non-cirrhotic portal hypertension, but inhibit the non-canonical hedgehog signaling and cirrhotic portal hypertension
por: Uschner, Frank E., et al.
Publicado: (2015)

Splenic arteriovenous fistula leading to non-cirrhotic portal hypertension: a case report: Splenic arteriovenous fistula leading to non-cirrhotic portal hypertension
por: Abou Yassine, Ahmad, et al.
Publicado: (2023)

Nitro-oxidative stress, VEGF and MMP-9 in patients with cirrhotic and non-cirrhotic portal hypertension
por: MUTI, LEON ADRIAN, et al.
Publicado: (2015)

Pathological abnormalities in splenic vasculature in non-cirrhotic portal hypertension: Its relevance in the management of portal hypertension
por: Gupta, Shahana, et al.
Publicado: (2020)

Delayed diagnosis of polycythaemia vera in an adult female with non-cirrhotic portal hypertension
por: Tachi, Kenneth, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_knqkcct6s786r7mpgd1p6jh6fk